On "Balance of Power: Evening Edition," Bloomberg's Michael Shepard discusses a forthcoming executive order from the Trump administration aimed at addressing AI security concerns without imposing mandatory pre-release reviews of AI models by government agencies.
NBA Hall of Famer Shaquille O'Neal & Authentic Brands CEO Jamie Salter discuss the launch of 'Dunkman,' a new dunk league aiming to compete with the NBA dunk contest. They talk with Romaine Bostick at the Milken Institute Global Conference in Beverly Hills, California.
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Isabelle Lee, Carol Massar and Tim Stenovec.
Carlyle Head of Global Research & Investment Strategy Jason Thomas discusses expectations of enormous AI productivity gains moving forward, and why US valuations are much more attractive now. He talks with Romaine Bostick at the Milken Institute Global Conference in Beverly Hills, California.
The era of "AI augmentation" — that polite corporate fiction where software was merely a "co-pilot" designed to help humans work faster — has ended.
In its place, 2026 has ushered in a period of cold, clinical replacement.
For decades, the global transition to renewable energy was a project of incrementalism — a slow-moving mosaic of carbon taxes, solar subsidies, and earnest international accords that often felt more aspirational than urgent.
Policy wonks argued over the nuances of the Inflation Reduction Act, while climate activists lamented the glacial pace of the "energy pivot."
For the better part of a decade, the gilded youth of the financial world — the "crypto-native" generation — dismissed gold as a "boomer rock."
To them, the heavy, yellow metal was an analog relic, a petrous souvenir of an era before the lightning-fast efficiency of the blockchain.
For years, the global defence industry existed in a sort of polite exile.
In the era of ESG mandates and the "peace dividend," shares in weapons manufacturers were often treated as the "tobacco stocks" of the new millennium — profitable, perhaps, but unseemly.
The RBA warns of two years of financial strain as rising fuel prices drive inflation, impacting groceries, construction, and household budgets across Australia.
RBA Governor Michele Bullock defends the hike to 4.35%, warning that the Iran war and oil shocks have "complicated" the inflation fight and increased recession risks.
Australian household spending went up by 1.6% in March, marking an acceleration from the modest gains seen at the start of the year.
New Zealand's annual inflation rate held firm at 3.1% for the March quarter, according to the latest consumer price index data released by Stats NZ.
The RBA warns of two years of financial strain as rising fuel prices drive inflation, impacting groceries, construction, and household budgets across Australia.
News Corp (ASX:NWS) reported a strong Q3 FY26, with revenue climbing 9% to US$2.19 billion.
The Australian Securities and Investments Commission has issued an urgent call to all licensees and market participants to fortify cyber resilience in the face of rapidly evolving frontier artificial intelligence.
Treasurer Jim Chalmers seeks "essential" new emergency powers for the ACCC to combat a global oil shock.
Block (ASX:XYZ) logged its quarterly performance and divulged an upward revision of its full-year profit forecast.
REA Group (ASX:REA) reported a strong Q3 with 11% revenue growth to $398 million and a 16% EBITDA rise.
Macquarie Group (ASX:MQG) has unveiled a financial performance for the year ended March 31, headlined by a net profit of $4.85 billion.
Swift TV (ASX:STV) secured official Netflix approval, becoming Australia's first enterprise TV provider to integrate the service via Google’s operator framework.
QBE Insurance Group (ASX:QBE) reported 11% premium growth to $9.2 billion in Q1 FY26, reaffirming its positive annual outlook.
Amplia Therapeutics (ASX:ATX) has partnered with the Australia New Zealand Gynaecological Oncology Group to launch a new clinical trial targeting ovarian cancer.
